Speaker illustration

Doctor Ana Marcano

IDIBELL, Bellvitge University Hospital, Heart Diseases Institute, L'Hospitalet de Llobregat, Barcelona (Spain)

Lack of impact on responsiveness to clopidogrel and aspirin of improving glycaemic control in patients with type 2 diabetes mellitus and stable coronary artery disease on dual antiplatelet therapy

Event: ESC CONGRESS 2017

Topic: Diabetes, dysglycaemia and metabolic syndrome

Session: Diabetes


Greater pharmacodynamic efficacy of ticagrelor compared to clopidogrel in patients with diabetes mellitus and stable coronary artery disease: a randomized investigation

Event: ESC CONGRESS 2017

Topic: Thrombosis and coagulation

Session: Antithrombotic strategies in coronary artery disease


Underuse of more potent P2Y12 antagonists in elderly patients, despite having worse response to clopidogrel compared to younger patients

Event: ESC CONGRESS 2016

Topic: Elderly and cardiovascular diseases

Session: Are we better at managing cardiovascular disease in the elderly?


This platform is supported by

logo Novo Nordisk